30 Jul 2026
From insight to innovationProbi was born out of a visionary research project at Lund University, Sweden, whose aim was to discover whether administering specific probiotics to critically ill patients could enhance therapeutic outcomes and improve their chances of recovery.
Based on the success of this project, which began in the mid-1980s, a patent application was filed for Lactiplantibacillus plantarum 299v (LP299V®) today the company’s most studied bacterial strain. This research was the genesis of Probi's founding in 1991.
Listen to the story about saving lives, our foundation and how our Probi vision started.
Video
MP4 90.9 MB
To proceed please sign up (free buyer account) or log in (if you already have an account).
Log in